From Target to Market - the GLA Biotech & Pharma Summer School (English)

Monique Wüstenhagen, Berlin Partner GmbH
Gläsernes Labor Akademie
Campus Berlin-Buch GmbH
Robert-Rössle-Straße 10
13125 Berlin
Tel.: +49 (0) 30 / 94 89 29 35

The 4-day intensive course provides a comprehensive overview of the entire drug development process in biotechnology and in the pharmaceutical industry – from the idea until to market.

The trainer team consists of experts from medicine, pharmaceutical industry, biotech companies, contract research and consulting organizations etc.

Since the course modules illustrate the drug development step by step, attendees will become familiar during lectures and workshops with the complete process and will learn what the pharma industry and authorities is like.

Due to the compact, complete and competent course in a familiar atmosphere you will be able to

  • apply the lecture contents during interactive and case-related exercises within small learning groups coached by the trainers
  • get a deep insight into the process of drug development and build up contacts to industry experts
  • discuss your questions with the trainers

Course Language:

Attendees receive at the beginning of the course comprehensive paper documentation. The binders include printouts of all presentation slides and working sheets as used during the workshop sessions. All paper documents, links to further information and literature will be available electronically through a course sharepoint.


The qualification will be held from Wednesday, 31 Aug 2022 till Saturday, 03 Sep 2022, daily from 9:00 a.m. till 06.00 p.m. plus evening lectures and events.


The course is limited to a maximum of 20 participants and will only take place with a minimum of 6 attendees. Due to organizational reasons, an early registration is recommended.

Target Audience:

The course is directed to staff (Natural scientists, PhD students and postdocs of natural scientific and medical degree programs) working in fundamental research, biotechnology or in researching pharma companies having no or little experience in drug development.

Learning Goals:

After course completion, attendees will have a basic understanding of the entire drug development process in the pharmaceutical industry and in biotechnology. Thus, based on their individual background, they should be able to identify potential occupational fields in the industry and authorities dealing with drug development and drug approvals.


The participation of the course will be certified by the German Life Science Association VBIO “Verband Biologie, Biowissenschaften und Biomedizin” and the Gläsernes Labor Akademie (GLA).

Course fees:

1.683,00 € per participant plus VAT, course binders and catering according to program as attached. Participants of academical institutions pay 1.346,00 € plus 19% VAT. Assosciations which are members of the VBIO as well as private applicants will get a fee reduction of 10%. According to local law (§ 11 Berliner Bildungsurlaubsgesetzes BiUrlG) the course can be classed as educational leave.

Link zur Kursseite

© Gläsernes Labor Akademie
Letzte Änderungen: 17.03.2022